Frank Rimerman Advisors LLC Has $3.88 Million Position in Danaher Co. (NYSE:DHR)

Frank Rimerman Advisors LLC reduced its holdings in Danaher Co. (NYSE:DHR) by 0.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 16,907 shares of the conglomerate’s stock after selling 141 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Danaher were worth $3,881,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new stake in Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher in the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America bought a new stake in Danaher in the third quarter valued at approximately $39,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in Danaher in the third quarter valued at approximately $40,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $211.09 on Friday. The stock has a market cap of $150.87 billion, a P/E ratio of 39.98, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a fifty day moving average price of $220.07 and a two-hundred day moving average price of $240.82. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the company earned $2.09 earnings per share. As a group, equities analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Wall Street Analyst Weigh In

Several brokerages have commented on DHR. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research note on Wednesday, January 15th. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research report on Friday. Barclays lowered their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Jefferies Financial Group lowered their price objective on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Finally, Guggenheim started coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $277.76.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.